Skip to content

Clinical trials

Phase 4 Cardiovascular Diseases trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 4 Country / region: Germany Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20051
20071
20092
20111
20121
20151
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Pfizer2
AstraZeneca1
Boehringer Ingelheim1
IKFE Institute for Clinical Research and Development1
Menarini International Operations Luxembourg SA1
Novartis1
Royal Brompton & Harefield NHS Foundation Trust1
University Hospital Freiburg1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases11
Diabetes Mellitus, Type 23
Hypercholesterolemia2
Stroke2
Acute Coronary Syndrome1
Angina Pectoris1
Arthritis1
Cerebral Palsy1
Coronary Artery Disease1
Coronary Disease1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.